Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
McKay
Bill
B
Medtronic Sofamor Danek, Memphis, Tennessee 38132, USA.
Sandhu
Harvinder S
HS
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008159:Lumbar Vertebrae / Q000601:surgery*; D023421:Models, Animal; D010012:Osteogenesis / Q000187:drug effects*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013123:Spinal Fusion / Q000379:methods*; D014057:Tomography, X-Ray Computed; D016212:Transforming Growth Factor beta; D016896:Treatment Outcome
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2